Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

984
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
984
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

810
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
810
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.7K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.7K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

2.0K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Prognostic factors in idiopathic pulmonary fibrosis in a tunisian cohort].

Revue des maladies respiratoires·2021
Same author

Allergen Immunotherapy : Tunisian Society of Respiratory Diseases and Allergology Guidelines.

La Tunisie medicale·2018
Same author

Abstracts of the Communications of the Sixteenth Francophone Allergology Meetings Hammamet, 4-7 October 2017.

La Tunisie medicale·2018
Same author

[The importance of lung volumes in the investigation of heavy smokers].

Revue des maladies respiratoires·2014
Same author

[Epidural emphysema complicating bronchial asthma].

Revue de pneumologie clinique·2012
Same author

[Spontaneous pneumothorax associated with ankylosing spondylitis].

Revue de pneumologie clinique·2012

Related Experiment Video

Updated: Apr 28, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

17.1K

[Fight against tuberculosis in the world].

A El Kamel1, S Joobeur1, N Skhiri1

  • 1Service de pneumologie, hôpital universitaire F. Bourguiba, rue 1(er)-juin-1955, 5000 Monastir, Tunisie.

Revue De Pneumologie Clinique
|June 1, 2014
PubMed
Summary

Tuberculosis (TB) remains a global health challenge. Strategies like DOTS and the Stop TB Strategy aim to reduce incidence and mortality, with ongoing efforts for post-2015 elimination.

Keywords:
ControlContrôleDOTSResistant tuberculosisTB/VIHTraitementTreatmentTuberculoseTuberculose résistanteTuberculosisVIH

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.4K

Related Experiment Videos

Last Updated: Apr 28, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

17.1K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.4K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Global Health Security

Context:

  • Tuberculosis (TB) is a significant global health issue requiring continuous strategic intervention.
  • Past strategies, including DOTS (directly observed therapy short course) and the "Stop TB Strategy 2006-2015," have shown progress but insufficient to meet elimination goals.
  • The mid-point review in 2010 prompted an updated Global Plan to Stop TB (2011-2015) to reassess progress and refine targets.

Purpose:

  • To review progress of TB control strategies and update global plans towards TB elimination.
  • To define expected advancements in TB diagnosis, treatment, co-infection management (TB/HIV), and drug-resistant TB by 2015.
  • To guide the development of a post-2015 strategy incorporating risk factors and socioeconomic determinants for TB elimination by 2050.

Summary:

  • The Global Plan to Stop TB 2011-2015 updated targets for diagnosis, treatment, TB/HIV co-infection, and drug-resistant TB.
  • It outlined expected achievements in new diagnostic tests, medications, vaccines, and shorter treatment regimens.
  • The plan also highlighted the need to integrate risk factors like diabetes, malnutrition, and tobacco use into future elimination strategies.

Impact:

  • Progress towards halting and reversing TB incidence, prevalence, and mortality rates.
  • Advancements in TB diagnostics, therapeutics, and preventative measures, including for drug-resistant strains and TB/HIV co-infection.
  • Laying the groundwork for a comprehensive post-2015 strategy focused on TB elimination by 2050, addressing broader determinants of health.